Trial intelligence / Profile preview

Telmisartan vs Ramipril in ACS (TERACS)

NCT00702936Phase 4Unknown

Sponsor
Università Cattolica del Sacro Cuore
Start
Nov 2007
Primary completion
Aug 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of telmisartan in acute coronary syndrome (ACS) (2 arms), sponsored by Università Cattolica del Sacro Cuore. Primary endpoint: High sensitivity C-Reactive Protein. Status: unknown.

02

Drugs

telmisartan
03

Conditions

acute coronary syndrome (ACS)

Beyond the preview

Go deeper on NCT00702936.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00702936.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call